Max Rosett
Net worth: 2 M $ as of 31/07/2026
Net worth: 2 M $ as of 31/07/2026
Max Rosett currently works at Immunome, Inc. as CFO, Chief Accounting Officer & EVP-Operations since 2024.
Formerly, Mr. Rosett was Chief Operating Officer at MorphImmune, Inc. from 2022 to 2023 and Principal at Research Bridge Partners from 2021 to 2023.
Mr. Rosett completed graduate education at Georgia Institute of Technology in 2016 and undergraduate education at Yale University in 2012.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOME, INC. 0.09% | 23/07/2026 | 1,01,287 ( 0.09% ) | 2 M $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
| IMMUNOME, INC. | Director of Finance/CFO | 02/01/2024 |
| Companies | Position | End |
|---|---|---|
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Corporate Officer/Principal | 01/11/2023 |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Chief Operating Officer | 01/10/2023 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Georgia Institute of Technology
Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Finance |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions